[
    [
        {
            "time": "",
            "original_text": "复星医药(02196)为复星实业(香港)5000万美元贷款提供担保 大额借贷担保",
            "features": {
                "keywords": [
                    "复星医药",
                    "复星实业",
                    "贷款担保",
                    "5000万美元"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药(02196)为复星实业(香港)5000万美元贷款提供担保 大额借贷担保",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "复星医药(02196.HK)向子公司提供不超5000万美元担保 大额借贷担保",
            "features": {
                "keywords": [
                    "复星医药",
                    "子公司",
                    "担保",
                    "5000万美元"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药(02196.HK)向子公司提供不超5000万美元担保 大额借贷担保",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "7月10日",
            "original_text": "A股市场资金变动一览（7月10日）",
            "features": {
                "keywords": [
                    "A股",
                    "资金变动"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "A股市场资金变动一览（7月10日）",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "布局乙肝药品生产线，复星医药大涨6%",
            "features": {
                "keywords": [
                    "复星医药",
                    "乙肝药品",
                    "生产线",
                    "大涨6%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "布局乙肝药品生产线，复星医药大涨6%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "6月",
            "original_text": "6月医药大事件之榜单篇：多样性排名考验药企综合实力",
            "features": {
                "keywords": [
                    "医药",
                    "大事件",
                    "榜单",
                    "综合实力"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "6月医药大事件之榜单篇：多样性排名考验药企综合实力",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 3,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "港股异动︱收购葛兰素史克苏州公司布局乙肝药品生产线 复星医药(02196)反弹逾4%",
            "features": {
                "keywords": [
                    "复星医药",
                    "葛兰素史克",
                    "乙肝药品",
                    "生产线",
                    "反弹4%"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股异动︱收购葛兰素史克苏州公司布局乙肝药品生产线 复星医药(02196)反弹逾4%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "港股异动 | 复星医药涨超4% 子公司获乙肝药品生产线",
            "features": {
                "keywords": [
                    "复星医药",
                    "子公司",
                    "乙肝药品",
                    "生产线",
                    "涨超4%"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股异动 | 复星医药涨超4% 子公司获乙肝药品生产线",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "港股医药板块迅速走高 吉林长龙药业涨近5%",
            "features": {
                "keywords": [
                    "港股",
                    "医药板块",
                    "走高",
                    "吉林长龙药业",
                    "涨近5%"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股医药板块迅速走高 吉林长龙药业涨近5%",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "港股异动 | 药品股普涨 改革持续推进 获券商看好",
            "features": {
                "keywords": [
                    "港股",
                    "药品股",
                    "普涨",
                    "改革",
                    "券商看好"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股异动 | 药品股普涨 改革持续推进 获券商看好",
                "Correlation": 3,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "公告解读：中国平安耗资逾5亿元回购股份 累计回购金额己达50亿元",
            "features": {
                "keywords": [
                    "中国平安",
                    "回购股份",
                    "5亿元",
                    "累计回购50亿元"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "公告解读：中国平安耗资逾5亿元回购股份 累计回购金额己达50亿元",
                "Correlation": 1,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]